Em-Sos Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 27-07-2024
- Paid Up Capital ₹ 0.21 Cr
as on 27-07-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.42 Cr
as on 27-07-2024
- Satisfied Charges ₹ 0.34 Cr
as on 27-07-2024
- Revenue 33.60%
(FY 2023)
- Profit 69.27%
(FY 2023)
- Ebitda 23.13%
(FY 2023)
- Net Worth 124.24%
(FY 2023)
- Total Assets -16.17%
(FY 2023)
About Em-Sos Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.21 Cr.
The company currently has active open charges totaling ₹1.42 Cr. The company has closed loans amounting to ₹3.37 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Singh and Navneet Singh serve as directors at the Company.
- CIN/LLPIN
U33111DL2006PTC149066
- Company No.
149066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Em-Sos Medical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Singh  | Director | 22-May-2006 | Current |
| Navneet Singh | Director | 22-May-2006 | Current |
Financial Performance and Corporate Structure Insights of Em-Sos Medical.
Em-Sos Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.6% increase. The company also saw a substantial improvement in profitability, with a 69.27% increase in profit. The company's net worth Soared by an impressive increase of 124.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Em-Sos Medical?
In 2023, Em-Sos Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Emsos Aviation Private Limited
Active 12 years 4 monthsJyoti Singh and Navneet Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 05 Nov 2018 | ₹3.06 M | Open |
Bank Of India Creation Date: 16 Nov 2016 | ₹0.30 M | Open |
Bank Of India Creation Date: 13 Jul 2013 | ₹2.50 M | Open |
How Many Employees Work at Em-Sos Medical?
Unlock and access historical data on people associated with Em-Sos Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Em-Sos Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Em-Sos Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
